Göran Gannedahl

Dr. Gannedahl has a long experience from the medical and pharmaceutical industry within the functions medical affairs, clinical research and business development. Combined with his expertise in oncology, translational medicine as well as the U.S. Food and Drug Administration and the needed requirements of drug development such as Good Laboratory Practice (GLP) certification, gives him an edge in the field. He is a medical doctor from Karolinska Institute, has a Ph.D. in Medicine from Uppsala University and has held positions as Global Head of Science Operations at Novartis, VP of R&D in Medical Affairs at Pronova Biopharma, and Executive Global Medical Affairs Leader at AstraZeneca.